Open-Label Placebo Trial among Japanese Patients with Chronic Low Back Pain

Table 3

Responders at week 3 and week 12.

		Number of responders (%)		Number of responders (%)
		Week 3 (n = 26)	value	Week 12 (n = 24)	value
RMDQ (∆ ≤ −2)	TAU	11 (42.3%)	1.00	13 (54.2%)	0.56
	TAU + OLP	11 (42.3%)		15 (62.5%)
NRS (∆ ≤ −2)	TAU	7 (26.9%)	0.51	7 (29.2%)	0.23
	TAU + OLP	5 (19.2%)		11 (45.8%)

A responder is defined as one that shows changes of at least 2-point from the baseline value at each follow-up point.